Physician profile
Douglas Herriott
NPI 1700885860
$931.49
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $40.45 · 2021: $280 · 2022: $242 · 2023: $79.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $79.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $79.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $260.35 | 2019-2023 | Total30 |
| Allergan, INC. | $129.19 | 2022 | |
| Abb Con-Cise Optical Group LLC | $102.43 | 2021 | |
| Genzyme Corporation | $83.93 | 2019 | |
| Biotissue Holdings INC. | $81.98 | 2021 | |
| Shire North American Group INC | $65.96 | 2019 | |
| Oyster Point Pharma, INC. | $33.52 | 2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $31.16 | 2021-2022 | |
| Glaukos Corporation | $28.53 | 2022 | |
| Bausch & Lomb Americas INC. | $24.94 | 2023 | Infuse |
| Kala Pharmaceuticals, INC. | $24.58 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $23.10 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $20.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Herriott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.